firm enlists African
university students in diabetes war
in Africa are well placed to advance research
and development of new drugs to treat diabetes
(Xinhua) -- German Pharmaceutical giant
Merck through its biopharmaceutical division, Merck
Serono, has rolled out a training program targeting
students in Kenya, Uganda and Namibia to boost their
skills in diabetes prevention and management.
to a statement released on Wednesday, the three-year
diabetes capacity advancement program targets 1000
medical students from university of Nairobi alongside
select students from Makerere and University of
rising toll of diabetics all over the world
necessitates the urgency to prioritize care and
awareness to prevent the disease from turning into a
national epidemic. Through the leadership, faculty
members and students in the universities, this
program will seek to improve the healthcare sector
throughout Africa,” Merck Serono CEO Stefan
stressed that universities in Africa are well placed
to advance research and development of new drugs to
treat diabetes, as the disease spread across the
entire population due to lifestyle changes.
diabetes capacity advanced program will focus on
clinical research, supply chain integrity and
efficiency, community awareness and pharmaco-vigilance.
added that the new program will ensure diabetic people
and care givers have access to adequate information on
prevention and treatment of this non communicable
demonstrates our commitment to long-term partnership
for providing quality, affordable and equitable
healthcare alongside social-economic development in
Africa,” said Oschmann.
Serono has provided a grant to help medical students
in Kenya, Uganda and Namibia acquire advanced
professional knowledge on diabetes prevention,
treatment and management.
to a statement, the initiative will support the
development of educational programs such as accredited
clinical diabetes management training for
undergraduates in African universities.
future, the program will address the medical
education for healthcare providers in rural
areas,” said the statement.
should be in the frontline in advancing research to
boost prevention and cure of lifestyle diseases that
have strained healthcare infrastructure in Africa.
Principal, College of Health Sciences, University of
Nairobi, Isaac Kibwage, reiterated that quality
research will enrich current interventions to reduce
the burden of non communicable diseases in Kenya.
University is ready to support initiatives such as
Merck Serono’s capacity advancement program and
will link up with other institutions whose overall
mission is to combat emerging diseases such as
diabetes,” Kibwage said.
stressed the need to transform health sector in Kenya
through research and capacity development alongside
uptake of modern technology.
achieve sustainable development and vision 2030,
there is need to transform the health sector to
provide quality, accessible and equitable health
care and universities will help achieve this
goal,” said Kibwage.
has worsened disease burden in Kenya and according to
statistics from the ministry of health, 1.6 million
Kenyans are currently grappling with diabetes and the
figure could rise to 2.5 million by 2050.
you read it first at